Get started Log in

AZN — AstraZeneca Share News

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Market Cap
£218.75bn
Enterprise Value
£236.77bn
Revenue
$54.07bn

REG - AstraZeneca PLC - Calquence Phase III ELEVATE-TN trial met primary
06/06/2019 07:05Announcement
REG - AstraZeneca PLC - Block listing Interim Review
03/06/2019 15:05Announcement
REG - AstraZeneca PLC - Total Voting Rights
03/06/2019 15:00Announcement
REG - AstraZeneca PLC - Lynparza nearly doubled time patients lived with
03/06/2019 07:05Announcement
REG - AstraZeneca PLC - Pooled analyses of the roxadustat global Phase III
10/05/2019 07:05Announcement
REG - AstraZeneca PLC - Director/PDMR Shareholding
08/05/2019 14:00Announcement
REG - AstraZeneca PLC - Director Declaration
08/05/2019 11:00Announcement
REG - AstraZeneca PLC - Trastuzumab deruxtecan demonstrated clinically
08/05/2019 07:05Announcement
REG - AstraZeneca PLC - Calquence PhIII ASCEND trial met primary endpoint
07/05/2019 07:08Announcement
REG - AstraZeneca PLC - Qternmet XR approved in the US for type-2 diabetes
03/05/2019 07:06Announcement
REG - AstraZeneca PLC - Total Voting Rights
01/05/2019 15:00Announcement
REG - AstraZeneca PLC - Director/PDMR Shareholding
01/05/2019 12:05Announcement
REG - AstraZeneca PLC - Lynparza receives positive EU CHMP opinion for 1st
29/04/2019 07:05Announcement
REG - AstraZeneca PLC - Result of AGM
26/04/2019 17:50Announcement
REG - AstraZeneca PLC - AZN: Q1 2019 Results
26/04/2019 07:05Announcement
REG - AstraZeneca PLC - Lynparza approved in EU for the treatment of germl
10/04/2019 07:05Announcement
REG - AstraZeneca PLC Investor AB - Holding(s) in Company
04/04/2019 13:30Announcement
REG - AstraZeneca PLC - Director/PDMR Shareholding
03/04/2019 10:00Announcement
REG - AstraZeneca PLC - Total Voting Rights
02/04/2019 15:00Announcement
REG - FTSE Russell AstraZeneca PLC - Astrazeneca
01/04/2019 18:00Announcement